Zurich Cantonal Bank
CNST

Zurich Cantonal Bank’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Zurich Cantonal Bank’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,178
Closed -$74K – 2846
2021
Q2 		$74K Hold
2,178
– – ﹤0.01% 2346
2021
Q1 		$51K Hold
2,178
– – ﹤0.01% 2383
2020
Q4 		$63K Hold
2,178
– – ﹤0.01% 2371
2020
Q3 		$44K Buy
2,178
+1,357
+165% +$33.1K ﹤0.01% 2295
2020
Q2 		$25K Buy
+821
New +$29.6K ﹤0.01% 2423

Zurich Cantonal Bank's CNST Position: Q3 2021 in Review

Zurich Cantonal Bank sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 2,178 shares — an estimated $74K sold.

Zurich Cantonal Bank first reported a position in CNST in Q2 2020 and held it in 5 quarters. The position peaked at $74K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Zurich Cantonal Bank reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Zurich Cantonal Bank sold 2,178 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $74K.
  • Zurich Cantonal Bank first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 5 quarters.
  • Zurich Cantonal Bank's Constellation Pharmaceuticals, Inc. position peaked at $74K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Zurich Cantonal Bank's 13F filing for Q3 2021, filed 15 Nov 2021.